Tag: VenaSeal
VeClose trial reports “excellent” clinical and quality of life outcomes at...
The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up...
VeClose trial indicates 24-month non-inferiority of VenaSeal versus radiofrequency ablation
Two-year outcomes of the VeClose pivotal trial have been reported, showing a 94.3% closure rate and “continued non-inferiority results to radiofrequency ablation” when using...
WAVES trial shows 100% vein closure at one month with short...
A post-market evaluation of the VenaSeal closure system (Medtronic) has found that, at one month, 100% of treated veins remained closed, quality of life...
